
DROPLET DIGITAL PCR AS A MOLECULAR TOOL FOR THE DETECTION OF THE EGFR T790M MUTATION IN NSCLC PATIENTS WITH THE EGFR ACTIVATING MUTATIONS Durgut S, Salihefendić L, Pećar D, Čeko I, Mulahuseinović N, Izmirlija M, Konjhodžić R *Corresponding Author: Selma Durgut, MD, ALEA Genetic Center, Olovska 67, 71000 Sarajevo, Bosnia and Herzegovina; Mob.: +38761904549, Email: selma.durgut@agc.ba page: 21
|
MATERIALS AND METHODS
For this study, a total of 45 blood samples were col-
lected from NSCLC patients who had previously tested
positive for EGFR-activating mutations. The samples were
collected at the Alea Genetic Center in Sarajevo. The selec-
tion of blood samples was based on identified EGFR muta-
tions from lung adenocarcinoma tissue samples, and during
this study they were tested for the presence of T790M
mutation. The Alea Genetic Center did not perform the
analysis for EGFR-activating mutations, and patients were
selected according to their pathohistological and molecular
testing results from different institutions. In this study, we
concentrated solely on T790M mutation, activating EGFR
mutations were determined by laboratories that tested the
tissue samples.
Blood plasma was separated from the blood, with 1-4
ml taken from each sample and stored at a temperature of
-20˚C. The circulating free DNA (cfDNA) was extracted
from these plasma samples using QIAamp ® Circulating
Nucleic Acid Kit, following the manufacturer’s instruc-
tions [14] . To process plasma samples faster and more effi-
ciently, the QIAvac 24 Plus with the QIAvac Connecting
System and QIAGEN Vacuum Pump was used according
to the manufacturer’s instructions [15] . Extracted cfDNA was quantified using Qubit 3 Fluorometer ® and Qubit ® dsDNA
HS assay kit [16] . Starting DNA concentration for ddPCR
reaction was 15 ng for every sample. Using Bio-Rad
QX200 Droplet Digital PCR technology, all 45 samples
were tested for a specific EGFR T790M mutation and
its corresponding wild-type amplicons. The commercial
assay used for T790M mutation and wild-type amplicon
detection was PrimePCR™ ddPCR™ Mutation Detection
Assay Kit: EGFR WT for p.T790M, and EGFR p.T790M.
The multiplex assay was 20X concentrated and ddPCR
supermix for probes was 2X concentrated. In order to
portion each sample into droplets, they were placed into
a QX200 droplet generator. Droplets were then transferred
to a 96-well plate and placed into Bio-Rad T100 thermal
cycler. The amplification was performed according to the
manufacturer’s instructions [17] . After DNA amplification,
the droplet-containing plate was positioned in the QX200
droplet reader, allowing for the analysis of each droplet
individually through a two-color system (FAM and HEX/
VIC) [13] . For the analysis of the results, QuantaSoft Soft-
ware was used.
When processing the results, wild-type and mutant
T790M alleles were expressed as a number of FAM (mu-
tant) and HEX (wild-type) droplets. The frequency of
mutant alleles was determined by calculating the ratio
of mutant droplets to the sum of mutant and wild-type
droplets. Since ddPCR enables absolute quantification,
mutant cfDNA templates were expressed as a number of
copies per µl of tested DNA. The ddPCR threshold for
positive mutant alleles was set at two or more positive
droplets considering the added amount of DNA and gener-
ated number of droplets [18,19] .
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|